Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy

por Gold, Michael, Lorenzl, Stefan, Stewart, Alistair J, Morimoto, Bruce H, Williams, David R, Gozes, Illana
Publicado 2012

Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein

por Magen, Iddo, Ostritsky, Regina, Richter, Franziska, Zhu, Chunni, Fleming, Sheila M, Lemesre, Vincent, Stewart, Alistair J, Morimoto, Bruce H, Gozes, Illana, Chesselet, Marie-Françoise
Publicado 2014